ChemoMetec AS (OCSE:CHEMM) Forward Dividend Yield %: 1.89% (As of Jun. 28, 2026)


OCSE:CHEMM ChemoMetec AS OCSE:CHEMM
99 GF Score
Price kr370.60
GF Value kr523.33
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is ChemoMetec AS Forward Dividend Yield %?

ChemoMetec AS OCSE:CHEMM +0.38% 99 Forward Dividend Yield % is 1.89% as of Jun. 28, 2026. GuruFocus rates OCSE:CHEMM with a GF Score™ of 99/100 and a GF Value™ of kr523.33 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 315 Medical Devices & Instruments companies, ChemoMetec AS ranks worse than 53.97% on this metric.

As of today (2026-06-28), the Forward Annual Dividend Yield of ChemoMetec AS is 1.89%.

As of today (2026-06-28), the Trailing Annual Dividend Yield of ChemoMetec AS is 1.89%.

OCSE:CHEMM's Forward Dividend Yield % is ranked worse than
53.97% of 315 companies
in the Medical Devices & Instruments industry
Industry Median: 2.15 vs OCSE:CHEMM: 1.89

ChemoMetec AS's Dividends per Share for the six months ended in Dec. 2025 was kr7.00.

During the past 12 months, ChemoMetec AS's average Dividends Per Share Growth Rate was 75.00% per year.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of ChemoMetec AS was 58.70% per year. The lowest was 58.70% per year. And the median was 58.70% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


ChemoMetec AS  (OCSE:CHEMM) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


ChemoMetec AS Forward Dividend Yield % Related Terms


OCSE:CHEMM vs ABT, SYK, MDT: Forward Dividend Yield % Comparison

For the Medical Devices subindustry, ChemoMetec AS's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ChemoMetec AS Forward Dividend Yield % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ChemoMetec AS's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where ChemoMetec AS's Forward Dividend Yield % falls into.


OCSE:CHEMM
99GF Score
ChemoMetec AS OCSE:CHEMM
Forward Dividend Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ChemoMetec AS Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

ChemoMetec AS Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
DKK 7.0000002025-10-102025-10-132025-10-14Cash DividendannuallyDKK:DKK 1.000000

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.

ChemoMetec AS's Forward Annual Dividend Yield (%) for Today is calculated as

Forward Annual Dividend Yield=Forward Full Year Dividend/Current Share Price
=7/370.60
=1.89 %

Current Share Price is kr370.60.
ChemoMetec AS's Dividends per Share for the forward twelve months is calculated as kr7 * 1 = kr7.

ChemoMetec AS's Trailing Annual Dividend Yield (%) for Today is calculated as

Trailing Annual Dividend Yield=Most Recent Full Year Dividend/Current Share Price
=7/370.60
=1.89 %

Current Share Price is kr370.60.
ChemoMetec AS's Dividends per Share for the trailing twelve months (TTM) ended in Today is kr7.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Forward Dividend Yield % of 1.89% mean?
ChemoMetec AS (OCSE:CHEMM) has a Forward Dividend Yield % of 1.89% as of Jun. 28, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on ChemoMetec AS and its competitors. According to the industry distribution chart, ChemoMetec AS ranks #170 out of 315 companies in the Medical Devices & Instruments industry, placing it in the top 54%.
Is ChemoMetec AS's Forward Dividend Yield % too high?
ChemoMetec AS's current Forward Dividend Yield % is 1.89%. The Medical Devices & Instruments industry median Forward Dividend Yield % is 2.15. ChemoMetec AS's value of 1.89% is 12.1% below this industry median. Based on the distribution chart, ChemoMetec AS ranks #170 out of 315 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, ChemoMetec AS has a GF Score™ of 99/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does ChemoMetec AS's Forward Dividend Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, ChemoMetec AS ranks #170 out of 315 companies for Forward Dividend Yield %. This places ChemoMetec AS in the lower half of its industry. The industry median Forward Dividend Yield % is 2.15. ChemoMetec AS's value of 1.89% is 12.1% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Medical Devices & Instruments company?
The median Forward Dividend Yield % among Medical Devices & Instruments companies is 2.15, based on 315 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ChemoMetec AS's current Forward Dividend Yield % of 1.89% is 12.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on ChemoMetec AS and its competitors. For the Medical Devices & Instruments industry, the median Forward Dividend Yield % is 2.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ChemoMetec AS's current Forward Dividend Yield % is 1.89%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ChemoMetec AS stock overvalued right now?
Based on GuruFocus' analysis, ChemoMetec AS (OCSE:CHEMM) is currently considered Modestly Undervalued. The stock's GF Value™ is kr523.33, compared to a current price of kr370.60 — trading 29.2% below its estimated fair value. The current Forward Dividend Yield % is 1.89% and 12.1% below the Medical Devices & Instruments industry median of 2.15. ChemoMetec AS's overall GF Score™ is 99/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For ChemoMetec AS (OCSE:CHEMM), the current Forward Dividend Yield % is 1.89% as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ChemoMetec AS (OCSE:CHEMM) Overvalued in 2026?

Based on GuruFocus' analysis, ChemoMetec AS stock appears to be undervalued. The current stock price of kr370.60 is trading 29.2% below its estimated GF Value™ of kr523.33. GuruFocus considers ChemoMetec AS to be Modestly Undervalued.

Key valuation signals for OCSE:CHEMM:

  • Forward Dividend Yield %: 1.89%
  • GF Value™: kr523.33 vs. price of kr370.60 (29.2% below fair value)
  • GF Score™: 99/100 with 2 warning signs
  • Industry Position: 12.1% below the Medical Devices & Instruments median (#170 of 315)

No single metric tells the full story. See the OCSE:CHEMM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


ChemoMetec AS Business Description

Other Exchanges CHEMMc:UK0DZ0:UKCHY:Germany
Address Gydevang 43, Allerod, DNK, 3450
ChemoMetec AS specializes in designing, developing, and producing instruments using patented technology in cell counting and evaluation. It is engaged in the manufacturing and marketing of analytical instruments used for quantitative analysis of cells in liquids. Its applications include Cell Analysis and counting of Mammalian Cells, Yeast Cells, and Sperm Cells. It provides platforms for the determination of viability and cell count of yeast, veterinary semen, mammalian cells, and somatic cells as well as image analysis. It has four segments instruments; consumables; services and others, and the majority of its revenue is generated from the Consumable segment.
99GF Score

Get the complete analysis for OCSE:CHEMM

Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr370.60
Price
kr523.33
GF Value